367 related articles for article (PubMed ID: 17546636)
21. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma.
Samson KT; Minoguchi K; Tanaka A; Oda N; Yokoe T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2006 Apr; 36(4):475-82. PubMed ID: 16630152
[TBL] [Abstract][Full Text] [Related]
22. A possible role of TARC in antigen-specific Th2-dominant responses in patients with Paragonimiasis westermani.
Katoh S; Matsumoto N; Matsumoto K; Tokojima M; Ashitani J; Nakamura-Uchiyama F; Matsushima K; Matsukura S; Nawa Y
Int Arch Allergy Immunol; 2004 Jul; 134(3):248-52. PubMed ID: 15178895
[TBL] [Abstract][Full Text] [Related]
23. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
[TBL] [Abstract][Full Text] [Related]
24. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.
Imai T; Nagira M; Takagi S; Kakizaki M; Nishimura M; Wang J; Gray PW; Matsushima K; Yoshie O
Int Immunol; 1999 Jan; 11(1):81-8. PubMed ID: 10050676
[TBL] [Abstract][Full Text] [Related]
25. CC chemokine receptor 4 ligand production by bronchoalveolar lavage fluid cells in cigarette-smoke-associated acute eosinophilic pneumonia.
Nureki S; Miyazaki E; Ando M; Kumamoto T; Tsuda T
Clin Immunol; 2005 Jul; 116(1):83-93. PubMed ID: 15925835
[TBL] [Abstract][Full Text] [Related]
26. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
[TBL] [Abstract][Full Text] [Related]
27. Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo.
de Lavareille A; Roufosse F; Schandené L; Stordeur P; Cogan E; Goldman M
Eur J Immunol; 2001 Apr; 31(4):1037-46. PubMed ID: 11298328
[TBL] [Abstract][Full Text] [Related]
28. Effects of MAPK inhibitors on CCR4-mediated chemotaxis against thymus and activation-regulated chemokine (TARC/CCL17).
Moroi Y; Yu B; Urabe K; Koga T; Nakahara T; Dainichi T; Uchi H; Furue M
J Dermatol Sci; 2004 Dec; 36(3):186-8. PubMed ID: 15541643
[No Abstract] [Full Text] [Related]
29. Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy.
Brennand S; Sutton VR; Biagi J; Trapani JA; Westerman D; McCormack CJ; Seymour JF; Kennedy G; Prince HM
Br J Dermatol; 2005 Jun; 152(6):1199-205. PubMed ID: 15948982
[TBL] [Abstract][Full Text] [Related]
30. Increased CCR4 expression in cutaneous T cell lymphoma.
Ferenczi K; Fuhlbrigge RC; Pinkus J; Pinkus GS; Kupper TS
J Invest Dermatol; 2002 Dec; 119(6):1405-10. PubMed ID: 12485447
[TBL] [Abstract][Full Text] [Related]
31. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
[TBL] [Abstract][Full Text] [Related]
32. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege.
Ishida T; Ishii T; Inagaki A; Yano H; Komatsu H; Iida S; Inagaki H; Ueda R
Cancer Res; 2006 Jun; 66(11):5716-22. PubMed ID: 16740709
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
[TBL] [Abstract][Full Text] [Related]
34. Increase of CC chemokine receptor 4-positive cells in the peripheral CD4 cells in dogs with atopic dermatitis or experimentally sensitized to Japanese cedar pollen.
Maeda S; Ohmori K; Yasuda N; Kurata K; Sakaguchi M; Masuda K; Ohno K; Tsujimoto H
Clin Exp Allergy; 2004 Sep; 34(9):1467-73. PubMed ID: 15347382
[TBL] [Abstract][Full Text] [Related]
35. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first beta-strand of chemokine.
Sebastiani S; Danelon G; Gerber B; Uguccioni M
Eur J Immunol; 2005 Mar; 35(3):746-56. PubMed ID: 15714581
[TBL] [Abstract][Full Text] [Related]
36. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
37. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
Okamoto H; Koizumi K; Yamanaka H; Saito T; Kamatani N
J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
[TBL] [Abstract][Full Text] [Related]
38. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
Scand J Immunol; 2006 Aug; 64(2):155-63. PubMed ID: 16867161
[TBL] [Abstract][Full Text] [Related]
39. Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis.
Nureki S; Miyazaki E; Ando M; Ueno T; Fukami T; Kumamoto T; Sugisaki K; Tsuda T
Respir Med; 2008 Feb; 102(2):239-47. PubMed ID: 17949965
[TBL] [Abstract][Full Text] [Related]
40. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
